Obesity, inflammation, and atherosclerosis (original) (raw)

• Rosamond, W. et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25–e146 (2008).
  PubMed Google Scholar
• Olshansky, S. J. et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352, 1138–1145 (2005).
  Article CAS PubMed Google Scholar
• Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
  Article CAS PubMed Google Scholar
• Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860–867 (2006).
  Article CAS PubMed Google Scholar
• Ross, R. & Harker, L. Hyperlipidemia and atherosclerosis. Science 193, 1094–1100 (1976).
  Article CAS PubMed Google Scholar
• Steinberg, D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J. Lipid Res. 47, 1339–1351 (2006).
  Article CAS PubMed Google Scholar
• Steinberg, D. The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it—almost. J. Lipid Res. 47, 1–14 (2006).
  Article CAS PubMed Google Scholar
• Li, H., Cybulsky, M. I., Gimbrone, M. A. Jr & Libby, P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13, 197–204 (1993).
  Article PubMed Google Scholar
• Witztum, J. L. & Steinberg, D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785–1792 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Libby, P. Inflammation in atherosclerosis. Nature 420, 868–874 (2002).
  Article CAS PubMed Google Scholar
• Turinsky, J., O'Sullivan, D. M. & Bayly, B. P. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J. Biol. Chem. 265, 16880–16885 (1990).
  CAS PubMed Google Scholar
• Schenk S., Saberi, M. & Olefsky, J. M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992–3002 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015–3025 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Janeway, C. A., Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
  Article CAS PubMed Google Scholar
• Kawakami, A. et al. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ. Res. 103, 1402–1409 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Steinberg, D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I. J. Lipid Res. 45, 1583–1593 (2004).
  Article CAS PubMed Google Scholar
• Steinberg, D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans. J. Lipid Res. 46, 179–190 (2005).
  Article CAS PubMed Google Scholar
• Steinberg, D. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia. J. Lipid Res. 46, 2037–2051 (2005).
  Article CAS PubMed Google Scholar
• Gu, L. et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275–281 (1998).
  Article CAS PubMed Google Scholar
• Boring, L., Gosling, J., Cleary, M. & Charo, I. F. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894–897 (1998).
  Article CAS PubMed Google Scholar
• Veillard, N. R. et al. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res. 94, 253–261 (2004).
  Article CAS PubMed Google Scholar
• Braunersreuther, V. et al. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc Biol. 27, 373–379 (2007).
  Article CAS PubMed Google Scholar
• Lesnik P, Haskell, C. A. & Charo, I. F. Decreased atherosclerosis in CX3CR1−/− mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111, 333–340 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195–205 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185–194 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993).
  Article CAS PubMed Google Scholar
• Hotamisligil, G. S., Murray, D. L., Choy, L. N. & Spiegelman, B. M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl Acad. Sci. USA 91, 4854–4858 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Rocha, V. Z. & Libby, P. The multiple facets of the fat tissue. Thyroid 18, 175–183 (2008).
  Article PubMed Google Scholar
• Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Gordon, S. Macrophage heterogeneity and tissue lipids. J. Clin. Invest. 117, 89–93 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kanda, H. et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494–1505 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Weisberg, S. P. et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115–124 (2006).
  Article CAS PubMed Google Scholar
• Inouye, K. E. et al. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56, 2242–2250 (2007).
  Article CAS PubMed Google Scholar
• Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D. & Heinecke, J. W. Macrophage chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 57, 1254–1261 (2008).
  Article CAS PubMed Google Scholar
• Odegaard, J. I. et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116–1120 (2007) (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, K. et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell. Metab. 7, 485–495 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6, 508–519 (2006).
  Article CAS PubMed Google Scholar
• Mach, F. et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 104, 1041–1050 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Heller, E. A. et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113, 2301–2312 (2006).
  Article CAS PubMed Google Scholar
• van Wanrooij, E. J. et al. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 251–257 (2008).
  Article CAS PubMed Google Scholar
• Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
  Article CAS PubMed Google Scholar
• Frostegard, J. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145, 33–43 (1999).
  Article CAS PubMed Google Scholar
• Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23–35 (2003).
  Article CAS PubMed Google Scholar
• Friesel, R., Komoriya, A. & Maciag, T. Inhibition of endothelial cell proliferation by gamma-interferon. J. Cell Biol. 104, 689–696 (1987).
  Article CAS PubMed Google Scholar
• Hansson, G. K., Hellstrand, M., Rymo, L., Rubbia, L. & Gabbiani, G. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170, 1595–1608 (1989).
  Article CAS PubMed Google Scholar
• Amento, E. P., Ehsani, N., Palmer, H. & Libby, P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11, 1223–1230 (1991).
  Article CAS PubMed Google Scholar
• Buono, C. et al. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23, 454–460 (2003).
  Article CAS PubMed Google Scholar
• Gupta, S. et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752–2761 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Davenport, P. & Tipping, P. G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163, 1117–1125 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• King, V. L., Szilvassy, S. J. & Daugherty, A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice. Arterioscler. Thromb. Vasc. Biol. 22, 456–461 (2002).
  Article CAS PubMed Google Scholar
• Stemme, S. et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl Acad. Sci. USA 92, 3893–3897 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Kol, A., Sukhova, G. K., Lichtman, A. H. & Libby, P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98, 300–307 (1998).
  Article CAS PubMed Google Scholar
• O'Connor, C. M. et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290, 1459–1466 (2003).
  Article CAS PubMed Google Scholar
• Grayston, J. T. et al. Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 352, 1637–1645 (2005).
  Article CAS PubMed Google Scholar
• Caligiuri, G. et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9, 10–17 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Mallat, Z. et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930–934 (2001).
  Article CAS PubMed Google Scholar
• Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178–180 (2006).
  Article CAS PubMed Google Scholar
• Wu, H. et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115, 1029–1038 (2007).
  Article CAS PubMed Google Scholar
• Rocha, V. Z. et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103, 467–476 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kintscher, U. et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28, 1304–1310 (2008).
  Article CAS PubMed Google Scholar
• Clarke, M. C. et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat. Med. 12, 1075–1080 (2006).
  Article CAS PubMed Google Scholar
• Geng, Y. J. & Libby, P. Progression of atheroma: a struggle between death and procreation. Arterioscler. Thromb. Vasc. Biol. 22, 1370–1380 (2002).
  Article CAS PubMed Google Scholar
• Clarke, M. C. & Bennett, M. R. Cause or consequence: what does macrophage apoptosis do in atherosclerosis? Arterioscler. Thromb. Vasc. Biol. (2008).
• Cinti, S. et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347–2355 (2005).
  Article CAS PubMed Google Scholar
• Mach, F., Schönbeck, U., Bonnefoy, J. Y., Pober, J. S. & Libby, P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96, 396–399 (1997).
  Article CAS PubMed Google Scholar
• Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333–336 (2002).
  Article CAS PubMed Google Scholar
• Arkan, M. C. et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191–198 (2005).
  Article CAS PubMed Google Scholar
• Yuan, M. et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673–1677 (2001).
  Article CAS PubMed Google Scholar
• Van Gaal, L. F., Mertens, I. L. & De Block, C. E. Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880 (2006).
  Article CAS PubMed Google Scholar
• Ridker, P. M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49, 2129–2138 (2007).
  Article CAS PubMed Google Scholar
• Everett, B. M., Kurth, T., Buring, J. E. & Ridker, P. M. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J. Am. Coll. Cardiol. 48, 2235–2242 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ridker, P. M., Stampfer, M. J. & Rifai, N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285, 2481–2485 (2001).
  Article CAS PubMed Google Scholar
• Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973–979 (1997).
  Article CAS PubMed Google Scholar
• Ridker, P. M., Rifai, N., Rose, L., Buring, J. E. & Cook, N. R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557–1565 (2002).
  Article CAS PubMed Google Scholar
• Koenig, W., Löwel, H., Baumert, J. & Meisinger, C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109, 1349–1353 (2004).
  Article PubMed Google Scholar
• Pai, J. K. et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 351, 2599–2610 (2004).
  Article CAS PubMed Google Scholar
• Ballantyne, C. M. et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 109, 837–842 (2004).
  Article CAS PubMed Google Scholar
• Danesh, J. et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350, 1387–1397 (2004).
  Article CAS PubMed Google Scholar
• Cushman, M. et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 112, 25–31 (2005).
  Article CAS PubMed Google Scholar
• Laaksonen, D. E. et al. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur. Heart J. 26, 1783–1789 (2005).
  Article CAS PubMed Google Scholar
• Pearson, T. A. et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499–511 (2003).
  Article PubMed Google Scholar
• Ridker, P. M. et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 118, 2243–2251 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ridker, P. M., Buring, J. E., Rifai, N. & Cook, N. R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297, 611–619 (2007).
  Article CAS PubMed Google Scholar
• Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H. & Harris, T. B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131–2135 (1999).
  Article CAS PubMed Google Scholar
• Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E. & Ridker, P. M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327–334 (2001).
  Article CAS PubMed Google Scholar
• Yudkin, J. S., Stehouwer, C. D., Emeis, J. J. & Coppack, S. W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972–978 (1999).
  Article CAS PubMed Google Scholar
• Katagiri, H., Yamada, T. & Oka, Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ. Res. 101, 27–39 (2007).
  Article CAS PubMed Google Scholar
• Berg, A. H. & Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939–949 (2005).
  Article CAS PubMed Google Scholar
• Lihn, A. S., Pedersen, S. B. & Richelsen, B. Adiponectin: action, regulation and association to insulin sensitivity. Obes. Rev. 6, 13–21 (2005).
  Article CAS PubMed Google Scholar
• Pajvani, U. B. et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152–12162 (2004).
  Article CAS PubMed Google Scholar
• Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y. & Libby, P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin. Sci. (Lond.) 110, 267–278 (2006).
  Article CAS Google Scholar
• Ridker, P. M. et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98, 839–844 (1998).
  Article CAS PubMed Google Scholar
• Ridker, P. M. et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344, 1959–1965 (2001).
  Article CAS PubMed Google Scholar
• Ridker, P. M. et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352, 20–28 (2005).
  Article CAS PubMed Google Scholar
• Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008).
  Article CAS PubMed Google Scholar
• Brown, J. D. & Plutzky, J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115, 518–533 (2007).
  Article CAS PubMed Google Scholar
• Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707–721 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sidhu, J. S., Cowan, D. & Kaski, J. C. The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients. J. Am. Coll. Cardiol. 42, 1757–1763 (2003).
  Article CAS PubMed Google Scholar
• Pfutzner, A. et al. Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. J. Am. Coll. Cardiol. 45, 1925–1931 (2005).
  Article CAS PubMed Google Scholar
• Li, A. C. et al. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106, 523–531 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Li, A. C. et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114, 1564–1576 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Dormandy, J. A. et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366, 1279–1289 (2005).
  Article CAS PubMed Google Scholar
• Nissen, S. E. & Wolski, K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356, 2457–2471 (2007).
  Article CAS PubMed Google Scholar
• Jandeleit-Dahm, K. A., Calkin, A., Tikellis, C. & Thomas, M. Direct antiatherosclerotic effects of PPAR agonists. Curr. Opin. Lipidol. 20, 24–29 (2009).
  Article CAS PubMed Google Scholar
• Fleischman, A., Shoelson, S. E., Bernier, R. & Goldfine, A. B. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289–294 (2008).
  Article CAS PubMed Google Scholar
• Koska, J. et al. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 52, 385–393 (2009).
  Article CAS PubMed Google Scholar
• Hansson, G. K. Atherosclerosis—an immune disease: The Anitschkov Lecture 2007. Atherosclerosis 202, 2–10 (2009).
  Article CAS PubMed Google Scholar
• Sheikine, Y. A. & Hansson, G. K. Chemokines as potential therapeutic targets in atherosclerosis. Curr. Drug Targets 7, 13–27 (2006).
  Article CAS PubMed Google Scholar
• Ni, W. et al. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 103, 2096–2101 (2001).
  Article CAS PubMed Google Scholar
• Inoue, S. et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106, 2700–2706 (2002).
  Article CAS PubMed Google Scholar
• Tamura, Y. et al. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arterioscler. Thromb. Vasc. Biol. 28, 2195–2201 (2008).
  Article CAS PubMed Google Scholar
• Braunersreuther, V. et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler. Thromb. Vasc. Biol. 28, 1090–1096 (2008).
  Article CAS PubMed Google Scholar
• Combadiere, C. et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107, 1009–1016 (2003).
  Article CAS PubMed Google Scholar